A Swiss life science company, spin-off of UZH, developing personalized skin tissue therapy to treat skin defects and beyond.
Products, services, technology
CUTISS is the only late-stage clinical TechBio company developing skin tissue therapeutics and dedicated to bioengineering. We are transforming skin surgery with denovoSkin™, our first-in-class personalized tissue therapy that enables automated, on-demand production of living skin at scale.
Developed for patients requiring skin surgery – from massive burns to reconstructive and aesthetic applications – denovoSkin™ has shown long-term safety and efficacy compared to the standard of care.
Some insights
Our mission is to revolutionize skin surgery and advance dermatology through personalized tissue therapies, leveraging cutting-edge automation to ensure scalability, precision, and global patient accessibility.
